Tue, 19 Jun 2018 06:36:10 GMT
Roche set to acquire rest of Foundation Medicine for $2.4B
Roche Holding, the Swiss drugmaker, agreed to acquire the rest of the US genomic profiling group Foundation Medicine in a deal worth $2.4B, bringing the value of the company to $5.3B.